Skip to content

Chemotherapy: Point of Care Monitoring Device for Imatinib Drug

Efficient electrochemical method (TRL 3) to measure concentration of anticancer drug Imatinib in patient’s plasma, for personalized medicine

Published: 14th January 2020
Chemotherapy: Point of Care Monitoring Device for Imatinib Drug
Header image provided by the university
Patents
  • IT: 102019000008808 PCT:IB2020/055545
IP Status
  • Patent application submitted
Seeking
  • Licensing
  • Development partner